Evonik Industries announces a capacity increase of ThreAmino (L-threonine) at Evonik Agroferm, a affiliated company of Evonik, in Kaba, Hungary. The German Company also plans amino acids capacity expansion in Singapore and the US.
Essen, Germany – The nameplate capacity at Evonik-Site at Kaba, Hungary, is expected to be expanded to 30,000 metric tons L-threonine per annum, which represents an increase of 10,000 metric tons. The new capacity is scheduled to come on stream in the third quarter of 2013. The additional quantities shall serve the growing demand.
“This expansion will transform the Hungarian site into a world-scale plant with state-of-the-art technology. It is our ambition that all investment projects lead to a significant performance improvement of the process and the product form. This shall help us to meet rising needs and requirements of our customers,” explains Dr Walter Pfefferle, head of Bioproducts business line of Evonik.
Capacity Expansion also at Evonik-Sites in Singapore and in the USA
The ThreAmino expansion complements two recent expansion announcements by Evonik, namely the construction of a new 150,000 metric ton MetAmino (DL-methionine) production complex on Jurong Island, Singapore, which is scheduled to come on stream in 2014, and the expansion of Biolys (L-lysine source) to an annual capacity of 280,000 metric tons in Blair, Nebraska, USA, by the end of 2012.